COVID-19 Emergency Ventilator

In response to the COVID-19 outbreak, Imperial’s experts in medical device design (bioengineering) – and a clinician treating infected patients – have designed an emergency ventilator that can be built to meet MHRA and FDA requirements using generic parts.  JAMVENT provides a simple, low-cost solution to ventilator shortages worldwide, particularly for health services in developing countries. Plus the robust design also makes it suitable for long term use beyond current COVID-19 needs.

The design document for the JAMVENT ventilator can be requested by those wishing to develop ventilators for their local healthcare providers and includes a list of parts and a software spec.

We welcome enquiries from health organisations, manufacturers and donors interested in working with us to take JAMVENT from design to manufacture.

 

Design benefits

  • Long term use – not specific to the COVID-19 crisis
  • Easy to manufacture from low cost components (estimated at around £1,500 in the UK)
  • Does not require specific pressure transducers or solenoids
  • Parts can be sourced from various manufacturers – avoiding supply-chain bottlenecks
  • No specialist or medical supply chain components – and no balloons
  • Simple electronics
  • Doesn’t require gas to drive it – unlike some others – which is critical where gas supply is limited.
  • Employs fluid mechanical design principles

 

Ventilator design meets clinicians needs

  • PEEP controllable electronically
  • Pressure Regulated Volume Control (PRVC) mode
  • Supports spontaneous breath
  • Maintains PEEP during suctioning

Performance evidence

Evidence that the JAMVENT prototype can perform to MHRA and ISO 80601 tests can be downloaded here.

It also highlights PRVC and spontaneous mode performance and how it can maintain PEEP during suctioning – critical functions of ICU ventilators for COVID-19 patients.

 

JAMVENT ventilator in action – click to view a video

 

Ventilator system

 


Creators of the emergency ventilator design

  • Project and Technical Lead – Dr Joseph Sherwood – RAEng Research Fellow, Department of Bioengineering. Research areas include biofluid mechanics, flow measurement/control, device design for research.
  • Clinical Lead – Dr. Jakob Mathiszig-Lee – Honorary Research Fellow and Senior Anaesthetic Registrar at the Royal Brompton Hospital. Department of Surgery and Cancer.
  • Project Manager – Prof James Moore – The Bagrit Chair in Medical Device Design, Department of Bioengineering. Research areas include biofluid mechanics, cardiovascular device design, device translation.
  • Co-Technical Lead – Dr Michael Madekurozwa, Department of Bioengineering. Research areas include experimental biofluid dynamics, design and implementation of tools, hardware and software for use in research.

Who to contact:

Anne Freitag

Anne Freitag

Engagement Manager

For Materials, Bioengineering, Chemical Engineering, Computing, Earth Sciences, Cyber Security, Data Science, AI, 

Tel: +44 (0)20 7594 6572

Email me

All areas of expertise:

Related Insights

Life after lockdown: Transport

Life after lockdown: Transport

COVID-19 has changed everything. Or has it? How can transport companies, commuters and consumers adjust? Planes, trains and automobiles - best practice, e-mobility and air quality discussed. read more

Decision-making under uncertainty

Decision-making under uncertainty

Decision-making under uncertainty - Read how Imperial academics are helping companies maximise performance even in highly uncertain times. read more

Robotic revolution

Robotic revolution

Robots are already used to pick and pack online deliveries, vacuum our homes, and to enable surgeons to carry out life-saving operations. In the coming decades, robots have the potential to further enhance human capabilities, providing better care, more efficient transport, and tackling mundane tasks. read more

Related case studies

Scottish health service delivery and performance

Scottish health service delivery and performance

Our consultants shared their expertise in acute medicine and experience of working for governmental organisations and the NHS to help NHS Scotland and the Scottish Government to improve efficiency and quality in the Scottish health service. read more

Paediatric HIV symposium – 20th International AIDS Conference

Paediatric HIV symposium – 20th International AIDS Conference

Our consultants shared their expertise in anti-retroviral drugs, HIV infections/paediatric HIV to help ViiV Healthcare deliver symposia on growing the future leaders in paediatric HIV at the International Aids Conference 2014. read more

Cystic Fibrosis clinical advisory board

Cystic Fibrosis clinical advisory board

Our consultants shared their expertise in Cystic Fibrosis (CF), drug development and clinical trials to help Proteostasis Therapeutics assess the combination of compounds aimed at treatments to improve lung function. read more

Latest news

Decision-making under uncertainty – online event

Decision-making under uncertainty – online event

Visit us at Imperial Business Partners "Decision-making under uncertainty" online event 25 Feb from 11-12:30 to discuss your business needs. read more

Imaging and management of complex MCDA pregnancy – 26 August

Imaging and management of complex MCDA pregnancy – 26 August

Live, ISUOG approved interactive session by European and Asian experts on the latest research on managing complex MCDA twins. For fetal medicine experts, radiologists, obstetricians, sonographers, specialist midwives, neonatologists and trainees in these fields. Starts 12 noon (UK) read more

DISPERSE: 25 years old and counting!

DISPERSE: 25 years old and counting!

DISPERSE, a interactive software package for studying guided sound waves, celebrates it's 25th anniversary by launching a new upgrade with user friendly solutions for complex problems. read more